Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-23-005029
Filing Date
2023-06-09
Accepted
2023-06-09 16:34:07
Documents
2
Period of Report
2023-06-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4234
2 POWER OF ATTORNEY poaseitz.txt EX-24 3847
  Complete submission text file 0001562180-23-005029.txt   9494
Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Issuer) CIK: 0001770121 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SANA BIOTECHNOLOGY, INC. 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102
Business Address
Seitz Michelle (Reporting) CIK: 0001836301 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39941 | Film No.: 231005870